Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Quality Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Quality Index of 1.66x as of September 2025. Operating cash flow of CN¥21.03 Million exceeds net income of CN¥12.65 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Shanghai Yizhong Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688091 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year earnings quality comparison for Shanghai Yizhong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see how much is Shanghai Yizhong Pharmaceutical Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 5.65x | CN¥39.44 Million | CN¥6.98 Million | ▲ +955.3% |
| 2023 | 0.54x | CN¥86.55 Million | CN¥161.55 Million | ▼ -30.9% |
| 2022 | 0.78x | CN¥110.78 Million | CN¥142.85 Million | — |